Treatment of toxoplasmosis usually uses a combination of sulfadiazine (SDZ) and pyrimethamine, which demonstrate a remarkable synergistic activity against the replication of tachyzoites through the sequential inhibition of parasite dihydropteroate synthase (DHPS) and dihydrofolate reductase (DHFR). This evidence concerns the gene DHFR and toxoplasmosis.